Related Experiment Video
Updated: Jun 12, 2026

03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
Lung sealant and morbidity after pleural decortication: a prospective randomized, blinded study
Luca Bertolaccini1, Paraskevas Lybéris, Emilpaolo Manno
1Thoracic Surgery Unit, S, Croce Hospital, Cuneo, Italy. luca.bertolaccini@unito.it
Journal of Cardiothoracic Surgery
|June 1, 2010
Summary
The Pleuraseal Lung Sealant System significantly reduced prolonged air leaks (AL) after pleural decortications for empyema. This effective sealant is suitable for routine use, even in contaminated pleural procedures, without increasing infection risk.
Area of Science:
- Thoracic surgery
- Pulmonary medicine
- Medical device innovation
Background:
- Prolonged postoperative air leaks (AL) are a significant source of morbidity following thoracic procedures.
- Empyema thoracis, a serious infection of the pleural space, often requires surgical intervention like pleural decortication.
- Managing air leaks effectively is crucial for patient recovery and reducing hospital stay.
Purpose of the Study:
- To evaluate the efficacy of the Pleuraseal Lung Sealant System in reducing air leaks after pleural decortications for empyema thoracis.
- To compare outcomes between patients treated with the lung sealant and a control group receiving standard care.
Main Methods:
- A prospective study involving 46 patients undergoing pleural decortication for empyema (excluding post-procedural and malignancy-related cases).
- Patients were randomized into a Control group or a Sealant group where Pleuraseal was applied to air leak sites.
- Key outcome measures included the incidence of AL, duration of chest drainage, hospital stay, C-reactive protein (CRP), and leukocyte counts, with blinded assessment.
Main Results:
- The Sealant group demonstrated a significantly lower incidence of persistent air leaks (30% vs. 78%, p = 0.012) compared to the Control group.
- Chest drains were removed significantly earlier in the Sealant group (median 3 days vs. 5 days, p = 0.05).
- While the Sealant group had a shorter hospital stay, the difference was not statistically significant (p = 0.121). No adverse effects or increased infectious markers (CRP, leukocytes) were observed.
Conclusions:
- The Pleuraseal Lung Sealant System effectively reduces air leaks following pleural decortications for empyema.
- The sealant is safe for routine use, even in procedures involving contaminated pleural spaces, as evidenced by stable infectious indexes.
- This innovation offers a promising solution for managing air leaks, potentially improving patient outcomes and resource utilization.
Related Concept Videos
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History: